Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jul;94(3):811–822. doi: 10.1111/j.1476-5381.1988.tb11592.x

Temperature-dependence of the kinetics of the binding of [3H]-(+)-N-methyl-4-methyldiphenhydramine to the histamine H1-receptor: comparison with the kinetics of [3H]-mepyramine.

J M Treherne 1, J M Young 1
PMCID: PMC1854054  PMID: 3179614

Abstract

1. The dissociation of [3H]-(+)-N-methyl-4-methyldiphenhydramine ([3H]-QMDP) from the histamine H1-receptor was markedly temperature-dependent. The t1/2 was 4 min at 37 degrees C and 16 h at 6 degrees C. The association rate constant, k1, was also temperature-dependent, but not to the same extent as k-1. 2. Plots of the observed rate constant for [3H]-QMDP-receptor complex formation, kon, versus [3H-QMDP] were linear at both 30 degrees C and 10 degrees C, consistent with the interaction of [3H]-QMDP with the H1-receptor being a simple, one-step equilibrium. 3. The ratio of the kinetic constants, k1/k-1, indicated that the affinity constant of [3H]-QMDP for the H1-receptor should increase with decreasing temperature. Measurement of (+)-QMDP antagonism of the contraction of longitudinal muscle strips from guinea-pig small intestine induced by histamine at 37 degrees C, 30 degrees C and 25 degrees C provided some evidence that the affinity of (+)-QMDP is greater at 25 degrees C than 37 degrees C. However, the flattening of the concentration-response curves for histamine at low concentrations of (+)-QMDP at 30 degrees C and 25 degrees C is consistent with a slow dissociation of the (+)-QMDP-receptor complex and hence an incomplete equilibration with the agonist. 4. Arrhenius plots for k1 and k-1 for [3H]-QMDP were linear between 37 degrees C and 6 degrees C. The activation energies, Ea, for complex formation and dissociation were 77 +/- 4 and 129 +/- 3 kJ mol-1, respectively. 5. An Arrhenius plot for k-1 for the dissociation of [3H]-mepyramine from the H1-receptor was also linear between 37 degrees C and 6 degrees C. The activation energy was 140 +/- 2 kJ mol-1. 6. Activation energies for complex formation with the H1-receptor, Eaf, and complex dissociation, Ead, were similar for [3H]-QMDP and [3H]-mepyramine. The energy difference, Eaf--Ead, equivalent to the enthalpy change, did not differ significantly for the two ligands (-52 and -48 kJ mol-1, respectively). The larger values of k1 and k-1 for [3H]-mepyramine compared to [3H]-QMDP imply the presence of an entropic component in the interaction. 7. The simplest explanation for these observations is that transfer from the aqueous phase into a hydrophobic region is a significant factor in antagonist-H1-receptor interaction. This would be entropically more favourable for [3H]-mepyramine, a tertiary amine, than for [3H]-QMDP, a quaternary amine.

Full text

PDF
811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook D. A., Krueger C. A., Michalchuk A. Temperature and histamine receptor function--what is really happening? Can J Physiol Pharmacol. 1985 Jun;63(6):751–755. doi: 10.1139/y85-124. [DOI] [PubMed] [Google Scholar]
  2. Eliard P. H., Rousseau G. G. Thermodynamics of steroid binding to the human glucocorticoid receptor. Biochem J. 1984 Mar 1;218(2):395–404. doi: 10.1042/bj2180395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hill S. J., Young J. M. Characterization of [3H]mepyramine binding to the longitudinal muscle of guinea pig small intestine. Mol Pharmacol. 1981 May;19(3):379–387. [PubMed] [Google Scholar]
  4. Järv J., Hedlund B., Bartfai T. Isomerization of the muscarinic receptor . antagonist complex. J Biol Chem. 1979 Jul 10;254(13):5595–5598. [PubMed] [Google Scholar]
  5. Korner M., Bouthenet M. L., Ganellin C. R., Garbarg M., Gros C., Ife R. J., Sales N., Schwartz J. C. [125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain. Eur J Pharmacol. 1986 Jan 21;120(2):151–160. doi: 10.1016/0014-2999(86)90535-2. [DOI] [PubMed] [Google Scholar]
  6. Laduron P. M., Janssen P. F., Gommeren W., Leysen J. E. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole. Mol Pharmacol. 1982 Mar;21(2):294–300. [PubMed] [Google Scholar]
  7. Lohse M. J., Klotz K. N., Schwabe U. Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets. Mol Pharmacol. 1986 Mar;29(3):228–234. [PubMed] [Google Scholar]
  8. Plenge P., Mellerup E. T. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane. Biochim Biophys Acta. 1984 Feb 29;770(1):22–28. doi: 10.1016/0005-2736(84)90068-3. [DOI] [PubMed] [Google Scholar]
  9. Rhodes D. G., Sarmiento J. G., Herbette L. G. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol. 1985 Jun;27(6):612–623. [PubMed] [Google Scholar]
  10. Ross P. D., Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 1981 May 26;20(11):3096–3102. doi: 10.1021/bi00514a017. [DOI] [PubMed] [Google Scholar]
  11. Schreiber G., Henis Y. I., Sokolovsky M. Rate constants of agonist binding to muscarinic receptors in rat brain medulla. Evaluation by competition kinetics. J Biol Chem. 1985 Jul 25;260(15):8795–8802. [PubMed] [Google Scholar]
  12. Strader C. D., Sigal I. S., Register R. B., Candelore M. R., Rands E., Dixon R. A. Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4384–4388. doi: 10.1073/pnas.84.13.4384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tran V. T., Lebovitz R., Toll L., Snyder S. H. [3H]doxepin interactions with histamine H1-receptors and other sites in guinea pig and rat brain homogenates. Eur J Pharmacol. 1981 Apr 9;70(4):501–509. doi: 10.1016/0014-2999(81)90361-7. [DOI] [PubMed] [Google Scholar]
  14. Treherne J. M., Young J. M. [3H]-(+)-N-methyl-4-methyldiphenhydramine, a quaternary radioligand for the histamine H1-receptor. Br J Pharmacol. 1988 Jul;94(3):797–810. doi: 10.1111/j.1476-5381.1988.tb11591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wallace R. M., Young J. M. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor. Mol Pharmacol. 1983 Jan;23(1):60–66. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES